When was TyRx founded?

TyRx was founded in 1998 and raised its 1st funding round 6 years after it was founded.

Where is TyRx located?

TyRx is headquartered in Monmouth Junction, United States.

How many employees does TyRx have?

As of Oct 31, 2026, the latest employee count at TyRx is 19.

Is TyRx a funded company?

TyRx is a funded company, having raised a total of $70.8M across 9 funding rounds to date. The company's 1st funding round was a $***** Unattributed round, raised on Aug 2004.

When was the latest funding round of TyRx?

TyRx's latest funding was a $***** Series C round on May 15, 2013, with participation from 1 investor. Its primary sector is Cardiac and Vascular Disorders. In United States, the Cardiac and Vascular Disorders sector has seen $1.59B in funding in 2026 to date.

Where does TyRx rank among its competitors?

TyRx ranks 9th amongst 72 active competitors, of which 24 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was AtaCor Medical, which secured $75M in Oct, 2025.

Who are the top competitors of TyRx?

TyRx's top competitors include AtaCor Medical, EBR Systems and AtriCure. Among them, AtaCor Medical secured the most recent funding round in October, 2025.

TyRx - 2026 Company Profile, Team, Funding & Competitors

Q: Is TyRx an acquired company?

TyRx got acquired by Medtronic on Jan 06, 2014.

TyRx is an acquired company based in Monmouth Junction (United States), founded in 1998 by Jeffrey Wolf. It operates as an Antibacterial envelopes for cardiac implants. TyRx has raised $70.8M in funding from HLM Venture Partners and MemorialCare Innovation Fund. The company has 72 active competitors, including 24 funded and 21 that have exited. Its top competitors include companies like AtaCor Medical, EBR Systems and AtriCure.

Company Details

TYRX Antibacterial Envelopes help stabilize Cardiac Implantable Devices (CIEDs) while also helping to reduce Surgical Site Infections (SSIs) such as Pacemaker Pocket Infection. The company was acquired by Medtronic in 2014.

Key Metrics

Founded Year

1998

Location

Monmouth Junction, United States

Stage

Acquired

Total Funding

$70.8M in 9 rounds

Latest Funding Round

Series C, May 15, 2013, $*****

Investors

HLM Venture Partners & 7 more

Ranked

9^th among 72 active competitors

Employee Count

19 as on Oct 31, 2026

Similar Companies

AtaCor Medical & 91 more

Exit Details

Acquired by Medtronic (Jan 06, 2014)

View TyRx's full profile

TyRx is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
TYRX, INC CIN: 200096267 , United States, Active		-	42 (As on Dec 31, 2022)	-

TyRx got acquired by Medtronic on Jan 06, 2014 at an acquisition amount of $*****.

Click here to take a look at TyRx's acquisition in detail

TyRx has raised a total funding of $70.8M over 9 rounds. Its first funding round was on Aug 2004. Its latest funding round was a Series C round on May 15, 2013 for $*****. 1 investor participated in its latest round. TyRx has 8 institutional investors.

Here is the list of recent funding rounds of TyRx:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 15, 2013	8072591	Series C	2741214	5553434	7809417	4554359
Jan 02, 2013	4678580	Series C	3166017	5785075	3222462	2691864
Feb 10, 2012	3183439	Series C	8209225	8240534	4775021	2302174

Access funding benchmarks and valuations. Sign up today!

View details of TyRx's funding rounds and investors

The founders of TyRx is Jeffrey Wolf.

Here are the details of TyRx's key team members:

Jeffrey Wolf: Co-founder and Chairman of TyRx and founder of 1 other company.
Robert White: CEO of TyRx.

View details of TyRx's Founder profiles and Board Members

TyRx's employee count trend

TyRx has 19 employees as of Oct 26. Here is TyRx's employee count trend over the years:

Uncover TyRx's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of TyRx include AtaCor Medical, EBR Systems and AtriCure. Here is the list of Top 10 competitors of TyRx, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AtaCor Medical 2014, San Clemente (United States), Series D	Transforming cardiac rhythm management with innovative extravascular pacing and defibrillation solutions	$137M	aMoon, Broadview Ventures & 7 others	66/100
2nd	EBR Systems 2003, Sunnyvale (United States), Public	Revolutionizing cardiac rhythm management with leadless pacing technology for heart failure	$180M	Brandon Capital, M.H. Carnegie & Co & 12 others	63/100
3rd	AtriCure 2000, Mason (United States), Public	Medical device company focused on atrial fibrillation and pain management	-	Stage Capital, Camden Partners & 2 others	61/100
4th	CardioFocus 1990, Marlborough (United States), Series E	Endoscopically guided catheter for ablation	$261M	H.I.G. Capital, KBL & 23 others	60/100
5th	Kestra Medical Technologies 2014, Kirkland (United States), Public	Device to protect and support patients at risk of cardiovascular disorders	$196M	Bain Capital Life Sciences, Longitude Capital ... & 9 others	57/100
6th	CathVision 2013, Copenhagen (Denmark), Series B	Provider and developer of an AI-based cardiac ablation therapy software and device	$36.1M	Vaekstfonden, Borean Innovation & 6 others	54/100
7th	CAIRDAC 2016, Antony (France), Series A	Developer of smart devices for monitoring cardiac rhythm disorders	$18.9M	Bpifrance, Merieux Equity Partners & 6 others	49/100
8th	Cameron Health 2001, San Clemente (United States), Acqui-Hired	Subcutaneous Implantable Defibrillator	$158M	Alloy Ventures, Western Technology Investment ... & 14 others	48/100
9th	TyRx 1998, Monmouth Junction (United States), Acquired	Antibacterial envelopes for cardiac implants	$70.8M	Comerica, MemorialCare Innovation Fund & 6 others	48/100
10th	Append Medical 2016, Or Yehuda (Israel), Series A	Developer of a device for the left atrial appendage closure system	$11.8M	ALIVE, Shoni Health Ventures & 3 others	47/100